www.genethique.org

Bioethic information and analysis newsletter

Previous letter Previous Letter

Following Letter

Following Letter

N°78 - June 2006

The Newsletter index
Switzerland: lower health care insurance premiums for refusing abortion
Belgium: law organizes artificial reproduction
Palliative care: Should we fear the closing of units?
 

Switzerland: lower health care insurance premiums for refusing abortion

Abortion in Switzerland
In 1982, abortion reimbursement was imposed to private health insurance companies on presentation of a double medical opinion. Since 1 October 2002, a mere signature of the mother allows abortion until the 12th week and further, a single medical opinion is enough until the day before birth. Moreover, minors under 16 can abort without parents’ agreement.

The real cost of abortion
Since 1988, Pro Life, an association from Switzerland, made an economical demonstration that members are real risks for health insurance companies. This way, Helvetian health insurance companies propose to reduce from 10 to 40% premiums of complementary insurance for policyholders who refuse abortion and eventually medically assisted reproduction. The demonstration is made: people attached to respect of life have behaviour that enables savings in health field. Actually, the cost of abortion does not only consist of the act itself. International scientific studies recently published deserve attention. After abortion, women’s mortality rate globally increases by 60% in the following years, high prematurity increases by 70%, other researches indicate a high recidivism rate for abortion1.

A responsible behaviour
Pro Life members are aware faced with the trivialization of abortion and the rise of health expenditures: they commit themselves to refusing their right to a possible abortion reimbursement offered by the base obligatory insurance and to promoting respect of life at every stage.
Besides savings directly linked to abortion refusal, it was observed that generally pro-life members smoke less, drink less and are less depressed. The two more important Swiss health insurance companies are interested in pro-life members with a number continuously increasing.
Since 2004, Helsana and CSS groups offer them, via their partner funds SANSAN and Auxilia, their non-obligatory complementary insurances, with a preferential price.

Conscientious objection
Josef Zisyadis, national counsellor of the Popular Worker’s Party (POP), this spring, submitted an urgent proposal aimed at banning the insurers to concede « ethical » discounts. The Federal Council (Swiss high political authority) has just declared, on 30 May 2006, that there is no way of calling the principle of conscientious objection into question; as it happens, anybody has the right to refuse for himself a benefit from base obligatory insurance. In another hand, it confirms the liberty for health insurance companies to retrocede savings coming from a more responsible behaviour at least for private complementary insurance companies.

1. Deaths associated with Pregnancy Outcome: a Record Linkage Study of Low Income Women, Reardon et al. Southern Medical Journal, vol. 95, n°8, August 2002.

To the top of the page

 

Belgium: law organizes artificial reproduction

Every year, 12,000 in vitro fertilizations are performed in Belgium, between 2,500 and 3,000 children are born with these techniques and 3,700 out of 10,000 couples concerned, come from abroad. However, until now, reproductive medicine and human genetics were not object of a specific legislation, except two royal orders concerning standards of the centres for medically assisted procreation (AMP) and reimbursement modalities for in vitro fertilizations. The Belgian Senate has just voted the first law which organizes the MAP and the text should be definitive before the end of the current legislature.

To supervise the practices
The bill deals with « author(s) of the parental project », a vague notion concerning all couples, married or not, heterosexual or homosexual as well as singles. It fixes an age limit for women: 45 years maximum for oocyte sample and implantation; 47 years for embryo implantation and insemination. Minor patients (under 16) are excluded, unless medical exception (for instance, a young woman with cancer who wants to preserve her oocytes before a chemotherapy treatment). It authorizes pre-implantation diagnosis and the conception of “designer baby”.
Then, the text authorizes implantation and post-mortem implantation of supernumerary embryos if the father agrees as long as he lives.

Children: subject of a convention
The law foresees a convention between patients and centres for MAP, specifying their identity, age, address and the method used. The status of supernumerary embryos is mentioned, especially to settle awkward situations as a separation, an insolvable difference of opinion between the authors of the parental project, the death of one of them: cryopreservation during 5 years (except derogation), affectation to research or donation. 24,000 supernumerary embryos are frozen each year. In fact, research on supernumerary embryos and the creation of embryos for research are authorized in Belgium since May 2003.

The costs of MAP in Belgium
The cost of IVF is covered for people with complementary private health insurance in Belgium, including for homosexual persons. Each treatment costs 1,587 euros per cycle of which €170 must be paid by the patient. A woman can have a maximum of 6 IVF treatments. For 2001, medically assisted reproduction cost 20 million euros for 9,462 cycles with “fresh” embryo transfer and 2,410 cycles with frozen embryo transfer, 452 oocyte donations and 48 embryo donations. The success rate of an IVF is 20%. Regarding inseminations, 800 sperm inseminations with donor have been reported in 2002; the financial compensation is 50 euros per donation and the global price to access the sperm bank is 600 euros. 

The limits
Besides limits related to women age, the bill bans the simultaneous implantation of embryos coming from different donors of supernumerary embryos. It foresees that supernumerary embryos of a same donor or couple of donors cannot lead to childbirths in more than six different women. On the other hand, the law does not limit the number of oocytes that can be fertilized and even promotes the production of supernumerary embryos needed for research.

The questions in discussion concerning the rule of anonymity of the donor that opposes the “right” of the child to know its origins and the possibility of pairing (consisting in researching physical characteristics close to foster parents) which could not be considered as a practice with eugenic character. Finally, surrogate maternity (surrogate mother) is not mentioned nor prohibited.  

To the top of the page


 

Palliative care: Should we fear the closing of units?

"Palliative care: Should we fear the closing of units?" this was the theme of the day organized by Jeanne Garnier Medical House (Paris) at the national assembly, on last 9 May. While we are talking a lot about palliative care and Leonetti law of 25 April 2005 insists on the emergency to develop the accompaniment at the end of life, what is going on in France today?

Report of the Court of Accounts
A Court of Accounts report from September 20051 notices that France remains very different from recommendations of Social and Economic Council which advocates 5 beds for palliative care per 100,000 inhabitants (currently the average is 1.2 beds). It also insists on the inequalities of access to palliative care, for geographic (Centre, South-West of France, rural areas and those with a high old population being badly equipped with palliative care hospital structures) as well as pathologic level. If patients with cancer are relatively well accompanied, old people have a reduced access, as well as other patients with other pathologies, like advanced neurological, cardiac, pulmonary and Alzheimer diseases… Finally, the Court of Accounts regrets that the financial means allocated these last years to Regional hospitalisation agencies (ARH) for palliative care have not been integrally spent: the utilization rate of this budget was about 61% in 2001 and 40% in 2002. The ARH had to meet others priorities from Health Ministry…

The organization of palliative care
Three types of structures exist, which accompany patients at end of life:
-
Palliative care units (PCU) which provide care, training, education and clinical research, 78 in France;
-
Mobile palliative care team (MPCT), there are 326 but several French departments are still short on;
-
Palliative care networks and home care services (HCS), there are 93 in 58 French departments and 23 regions.

Worrying figures
In France, two out of three admission demands has a negative issue, and it is observed that the number of beds in PCU decreased by more than 6% between 2002 and 2003 (from 834 to 782) and that medical staff decreased from 107 to 91 for the same number of beds. Yet, Léonetti law, which leads to take decisions to limit or stop active treatment, naturally orientates numerous patients towards palliative care units that cannot accommodate them due to a lack of space

Satisfaction of families
94% of families have been satisfied or very satisfied with the pain management of their relatives. But a lot of them regrets they had to wait before being accommodated, due to the lack of space in palliative car units (55%) or the bad organization of health services.

Living place and school of life
A poll carried out towards families who had a hospitalized relative at Jeanne Garnier’s shows that for 67% of them, it is a living place and not a deathtrap and that time spent in this place was useful by enabling them to live an intense period and deep exchanges with their relatives. Palliative care units are also a school of life. While medicine students finish their studies without having received training worthy of the name as regards relationship and medical ethics, Marie de Hennezel proposes, in her report, an obligatory period in palliative care service during their studies. This measure is not yet feasible today, due to the reduced number of existing units.

1. Report never published and mentioned in La Croix, 9 May 2006.

 

  is a monthly newsletter, distributed free of charge, and published by the Jérôme Lejeune Foundation. Director of the Publication : Jean-Marie Le Méné - Editor in chief : Aude Dugast
31 rue Galande - 75005 Paris - France - Tel : +33 (0)1.55.42.55.14 - ISSN 1638-198 X
contact@genethique.org

 

Subscribe today to weekly Press Review or monthly Newsletter, it's free!

 

Traduction by A.R-TRADUCTION